Attached files
file | filename |
---|---|
8-K - LIVE FILING - IMMUNE PHARMACEUTICALS INC | htm_46824.htm |
January 7, 2013
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.1 of EpiCept Corporations Form 8-K dated January 7, 2013, and we agree with the statements made therein.
Yours truly,
/s/ Deloitte & Touche LLP